Log in
Enquire now
Asceneuron

Asceneuron

Asceneuron is a clinical-stage biotech company.

OverviewStructured DataIssuesContributors

Contents

asceneuron.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Clinical trial
Clinical trial
‌
Neurodegenerative Disease
Biotechnology
Biotechnology
Health technology
Health technology
Alzheimer's disease
Alzheimer's disease
Biomedical engineering
Biomedical engineering
Engineering
Engineering
Location
Switzerland
Switzerland
CEO
Number of Employees (Ranges)
1 – 10
Investors
EQT Life Sciences
EQT Life Sciences
‌
Novo A/S
Merck Serono Ventures (M Ventures)
Merck Serono Ventures (M Ventures)
0
Sofinnova Partners
Sofinnova Partners
OrbiMed
OrbiMed
Founded Date
2012
Total Funding Amount (USD)
100,000,000
Latest Funding Round Date
July 16, 2024
Latest Funding Type
Series C
Series C
Country
United States
United States
Switzerland
Switzerland
Headquarters
Lausanne
Lausanne

Other attributes

Latest Funding Round Amount (USD)
100,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Asceneuron

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.